Skip Navigation

2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary


This three-page guideline summary is a 2006 update of the American Society of Clinical Oncology's (ASCO) recommendations for the use of antiemetics in oncology.

This guideline summary addresses the following topics:

  • Chemotherapy-induced emesis
  • Radiation-induced emesis

Three tables summarize the following topics:

  • Antiemetic agents and regimens, emetic risk categories, special emetic problems, and radiation-induced emesis
  • Emetic risk of intravenously administered antineoplastic agents
  • Emetic risk of radiation regimens

A discussion, a description of the methodology, and information about additional resources are also presented.

Links to the Tool:
This tool is available at:


American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology

QualityTool Topic


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006:


  • Release Date: 07/2006
  • Original Summary: 08/2006
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Disease/Clinical Category:

Last updated: February 16, 2011.